Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|September 30, 2021
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvementAnnalisa Condorelli, Cristina Matteo, Salvatore Leotta, et al.
Scientific Reports|December 22, 2016
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imagingSilvia Giordano, Massimo Zucchetti, Alessandra Decio, et al.
International Journal of Cancer|May 13, 2018
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumabFrancesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinomaCarmen Belli, Lorenzo Piemonti, Maurizio D'Incalci, et al.
Nanomaterials (Basel, Switzerland)|March 25, 2017
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry ImagingSilvia Giordano, Valentina Pifferi, Lavinia Morosi, et al.
Targeted Oncology|December 28, 2020
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic ProfileDomenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, et al.
Molecular Cancer Therapeutics|October 24, 2015
Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor ResponseMarta Cesca, Lavinia Morosi, Alexander Berndt, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing DataGudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
International Journal of Nanomedicine|January 23, 2024
Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine XenograftsJesse Demuytere, Charlotte Carlier, Leen Van de Sande, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2021
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsLavinia Morosi, Marina Meroni, Paolo Ubezio, et al.
Pageof 10